News & Press Releases

As ISPE looks to the future, its community remains its greatest strength. With new technologies emerging, challenges ahead, and opportunities on the horizon, ISPE is dedicated to leading with purpose and empowering professionals in the life sciences field. Guided by its strategic vision and supported by its global membership, ISPE will continue to transform possibilities into progress and improve lives worldwide. Stay updated with the latest ISPE media coverage and press releases.

Media

Cell & Gene Covers the Session, Early Regulatory Alignment to Implement Next-Generation Sequencing at GMP Scale, to be Presented at the 2026 ISPE Annual Meeting & Expo

13 October 2026

As cell and gene therapy developers seek faster, more comprehensive approaches to viral safety testing, next-generation sequencing (NGS) is emerging as a promising technology for detecting adventitious agents at GMP scale. The topic will be explored

Learn More

Press Releases

ISPE Announces 2026–2027 ISPE International Board of Directors Election Results

2 October 2026

The 2026–2027 ISPE International Board of Directors has been announced. Newly elected Directors will assume their positions at the 2026 ISPE Annual Meeting & Expo. ISPE has announced the results of the 2026–2027 ISPE International Board of Directors

Learn More

close-up-photovoltaics-factory-expert-using-table-750pxt.jpg

Media

Biosimilar Development Covers 2026 ISPE Annual Meeting & Expo Upcoming Session, AI-Enabled Computerized System Validation (CSV)

30 September 2026

As pharmaceutical companies increasingly explore artificial intelligence to support CSV, industry experts are emphasizing that success depends not on blind trust in AI, but on understanding where it adds value and where human oversight remains

Learn More

Press Releases

ISPE Announces its 2026 ISPE Annual Meeting & Expo Keynote Speakers

29 September 2026

The 2026 ISPE Annual Meeting & Expo will take place from 18–21 October in Washington, D.C., USA, and virtually. ISPE has announced its planned keynote speakers for its largest event of the year, the 2026 ISPE Annual Meeting & Expo. The conference

Learn More

Media

Upcoming 2026 ISPE Annual Meeting & Expo Session, Autonomous Quality Systems – AI-Enabled Compliance, Covered by Pharmaceutical Online

28 September 2026

As pharmaceutical companies face mounting pressure to validate increasingly complex digital systems with limited resources, artificial intelligence is emerging as a valuable tool for streamlining validation activities. The topic will be a focal point

Learn More

Media

Bioprocess Online Covers 2026 ISPE Annual Meeting & Expo Upcoming Session on a Quality Management System That Anticipates Cell and Gene Therapy (CGT) Challenges

23 September 2026

As cell and gene therapies (CGT) continue to push the boundaries of personalized medicine, traditional quality management system (QMS) approaches are being tested by the unique challenges of early-stage development. These issues will be a key topic

Learn More

Pharma-4.0-tm--and-Biopharma-Conference-branding.jpg

Press Releases

ISPE Announces Keynote Speakers for its 2026 ISPE Pharma 4.0™ and Biopharma Conference

21 September 2026

The conference will take place 10–11 December in Berlin, Germany, and virtually. The conference will feature three technical tracks covering digital enablement, compliant operations, and practical biopharma manufacturing transformation through Pharma

Learn More

Media

Biosimilar Development Covers, Controls for Retrieval-Augmented GenAI in GxP, to be Presented at the 2026 ISPE Annual Meeting & Expo Upcoming Session

18 September 2026

As pharmaceutical companies seek to leverage generative artificial intelligence within regulated environments, retrieval-augmented generation (RAG) is gaining attention as a practical approach for balancing innovation with compliance. The topic will

Learn More

375_250-digital_research__biotech__scientific_innovation_gettyimages_2223712673.jpg

Media

Cell & Gene Covers the Session, Implement and Manage Risks for AI solutions in cGMP, to be Presented at the 2026 ISPE Annual Meeting & Expo

16 September 2026

As pharmaceutical manufacturers explore ways to integrate artificial intelligence into regulated operations, industry leaders are emphasizing that successful adoption depends as much on governance and risk management as it does on technology. These

Learn More

News & Press Releases

Cell & Gene Covers the Session, Early Regulatory Alignment to Implement Next-Generation Sequencing at GMP Scale, to be Presented at the 2026 ISPE Annual Meeting & Expo

ISPE Announces 2026–2027 ISPE International Board of Directors Election Results

Biosimilar Development Covers 2026 ISPE Annual Meeting & Expo Upcoming Session, AI-Enabled Computerized System Validation (CSV)

ISPE Announces its 2026 ISPE Annual Meeting & Expo Keynote Speakers

Upcoming 2026 ISPE Annual Meeting & Expo Session, Autonomous Quality Systems – AI-Enabled Compliance, Covered by Pharmaceutical Online

Bioprocess Online Covers 2026 ISPE Annual Meeting & Expo Upcoming Session on a Quality Management System That Anticipates Cell and Gene Therapy (CGT) Challenges

ISPE Announces Keynote Speakers for its 2026 ISPE Pharma 4.0™ and Biopharma Conference

Biosimilar Development Covers, Controls for Retrieval-Augmented GenAI in GxP, to be Presented at the 2026 ISPE Annual Meeting & Expo Upcoming Session

Cell & Gene Covers the Session, Implement and Manage Risks for AI solutions in cGMP, to be Presented at the 2026 ISPE Annual Meeting & Expo

About ISPE Resources

ISPE Membership